To Direct the Secretary of Health and Human Services to Conduct a Demonstration Program to Test Providing Preferential Treatment under the Medicare, Medicaid, and CHIP Programs for Certain Drugs and Biologicals Manufactured in the United States.

Author
United States. Congress (118th, 1st session : 2023). Senate [Browse]
Format
Databases
Language
English
Published/​Created
[Washington, D.C.] : [U.S. Government Publishing Office], 2023-
Description
1 online resource

Details

Subject(s)
Library of Congress genre(s)
Frequency
Updated irregularly
Notes
  • Batch processed record.
  • This record provides access to the versions of this bill or resolution published in the United States Government Publishing Office's (GPO) GovInfo system. To see the versions, use the GPO PURL. To see the actions related to this bill or resolution, use the Congress.gov URL.
  • At head of title: 118th Congress, 1st session.
  • Sponsor(s): Senator Tina Smith.
  • Cosponsor(s): Senator Tom Cotton.
  • Referred committee(s): Senate Committee on Finance.
  • Date of introduction: "November 15, 2023."
  • United States Congress chamber(s): United States Senate.
  • United States federal government branch: Legislative branch.
  • Access ID (GovInfo): BILLS-118s3311is.
  • Pagination at time of introduction: 7 pages.
  • In scope of the U.S. Government Publishing Office Cataloging and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
Source of description
GovInfo.gov metadata; title from caption of the introduced version (GovInfo, November 15, 2023).
Short title
American Made Pharmaceuticals Act of 2023
At head of title
S. 3311
OCLC
  • 1427744834
  • 1499604237
Statement on responsible collection description
Princeton University Library aims to describe library materials in a manner that is respectful to the individuals and communities who create, use, and are represented in the collections we manage. Read more...
Other views
Staff view

Supplementary Information